Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″ -or 4′-position

1. A compound of formula (I),

wherein

is 0 or 1;

A-B is —CH═CH— or —CH 2 —CH 2 —;

R 1 is C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl or C 2 -C 12 -alkenyl;

R 2 is C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl; or C 2 -C 12 -alkinyl; or C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl or C 2 -C 12 -alkinyl, which are substituted with one to five substituents selected from the group consisting of OH, halogen, CN, —N 3 , —NO 2 , C 3 -C 8 -cycloalkyl which is optionally substituted with one to three C 1 -C 6 -alkyl-groups, C 3 -C 8 -cycloalkenyl which is optionally substituted with one to three C 1 -C 6 -alkyl-groups, norbornylenyl-, C 3 -C 8 -halocycloalkyl, C 1 -C 12 -alkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkoxy, C 3 -C 8 -cycloalkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, C 3 -C 8 -cycloalkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 12 -alkylsulfinyl, C 3 -C 8 -cycloalkylsulfinyl, C 1 -C 12 -haloalkylsulfinyl, C 3 -C 8 -halocycloalkylsulfinyl, C 1 -C 12 -alkylsulfonyl, C 3 -C 8 -cycloalkylsulfonyl, C 1 -C 12 -haloalkylsulfonyl, C 3 -C 8 -halocycloalkylsulfonyl, —NR 4 R 6 , —X—C(═Y)—R 4 , —X—C(═Y)—Z—R 4 , —P(═O)(OC 1 -C 6 -alkyl) 2 , aryl, heterocyclyl, aryloxy, arylthio and heterocyclyloxy; wherein the aryl, heterocyclyl, aryloxy, arylthio and heterocyclyloxy groups are optionally depending on the substitution possibilities on the ring-substituted with one to five substituents selected form the group consisting of OH, Halogen, CN, NO 2 , C 1 -C 12 -alkyl, C 3 -C 8 -Cycloalkyl, C 1 -C 12 -Haloalkyl, C 1 -C 12 -alkoxy, C 1 -C 12 -Haloalkoxy, C 1 -C 12 alkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 6 -alkoxy-C 1 -C 6 alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, Si(C 1 -C 12 -alkyl) 3 , —X—C(═Y)—R 4 , —X—C(═Y)—Z—R 4 , aryl, aryloxy, heterocyclyl and heterocyclyloxy; or

R 2 is aryl, heterocyclyl C 3 -C 8 -Cycloalkyl, C 3 -C 8 -Cycloalkenyl; or aryl, heterocyclyl C 3 -C 8 -Cyclo-alkyl or C 3 -C 8 -Cycloalkenyl, which are optionally depending on the substitution possibilities on the ring-substituted with one to five substituents selected from the group consisting of OH, halogen, CN, NO 2 , C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 12 -haloalkyl, C 1 -C 12 -alkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, dimethylamino-C 1 -C 6 -alkoxy, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, methylendioxy, aryl, aryloxy, heterocyclyl and heterocyclyloxy; R 3 is C 3 -C 8 -alkyl;

X is O, NR 5 or a bond;

Y is O or S;

Z is O, S or NR 5

R 4 is H, C 1 -C 12 -alkyl which is optionally substituted with one to five substituents selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkoxy and CN; C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 12 -alkyl; or aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are—depending on the substitution—possibilities—optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl and C 1 -C 6 -haloalkoxy;

R 5 is H, C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, benzyl or —C(═O)—C 1 -C 12 -alkyl;

R 6 is H, C 1 -C 12 -alkyl which is optionally substituted with halogen, C 1 -C 6 -alkoxy, CN, C 2 -C 8 -alkenyl, C 2 -C 8 -haloalkenyl, C 2 -C 8 -alkinyl, C 1 -C 12 -Haloalkenyl, —X—C(═Y)—R 9 , —X—C(═Y)—Z—R 9 , —SO 2 —R 9 , aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 12 -alkyl; or aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are—depending on the substitution—possibilities optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl or C 1 -C 6 -haloalkoxy; or

R 4 and R 6 together are a three- to five membered alkylene bridge, wherein one of the methylene groups may be replaced by O, S or SO 2 ; and

R 9 is H, C 1 -C 12 -alkyl which is optionally substituted with one to five substituents selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkoxy and CN; C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 12 -alkyl; or aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are depending on the substitution possibilities optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl and C 1 -C 6 -haloalkoxy;

and, where applicable, to E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form.

2. A compound of formula (I),

wherein

n is 0 or 1;

A-B is —CH═CH— or —CH 2 —CH 2 —;

R 1 is C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl or C 2 -C 12 -alkenyl;

R 2 is C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl, C 2 -C 12 -alkinyl; or C 1 -C 12 -alkyl, C 2 -C 12 -alkenyl or C 2 -C 12 -alkinyl, which are substituted with one to five substituents selected from the group consisting of OH, halogen, ON, —N 3 , —NO 2 , C 3 -C 8 -cycloalkyl which is optionally substituted with one to three C 1 -C 6 -alkyl-groups, C 3 -C 8 -cycloalkenyl which is optionally substituted with one to three C 1 -C 6 -alkyl-groups, norbornylenyl-, C 3 -C 8 -halocycloalkyl, C 1 -C 12 -alkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkoxy, C 3 -C 8 -cycloalkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, C 3 -C 8 -cycloalkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 12 -alkylsulfinyl, C 3 -C 8 -cycloalkylsulfinyl, C 1 -C 12 -haloalkylsulfinyl, C 3 -C 8 -halocycloalkylsulfinyl, C 1 -C 12 -alkylsulfonyl, C 3 -C 8 -cycloalkylsulfonyl, C 1 -C 12 -haloalkylsulfonyl, C 3 -C 8 -halocycloalkylsulfonyl, —NR 4 R 6 , —X—C(═Y)—R 4 , —X—C(═Y)—Z—R 4 , —P(═O)(OC 1 -C 6 -alkyl) 2 , aryl, heterocyclyl, aryloxy, arylthio and heterocyclyloxy: wherein the aryl, heterocyclyl, aryloxy, arylthio and heterocyclyloxy groups are optionally depending on the substitution possibilities on the ring substituted with one to five substituents selected form the group consisting of OH, Halogen, CN, NO 2 , C 1 -C 12 -alkyl, C 3 -C 8 -Cycloalkyl, C 1 -C 12 -Haloalkyl, C 1 -C 12 -alkoxy, C 1 -C 12 -Haloalkoxy, C 1 -C 12 -alkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, Si(C 1 -C 12 -alkyl) 3 , —X—C(═Y)—R 4 , —X—C(═Y)—Z—R 4 , aryl, aryloxy, heterocyclyl and heterocyclyloxy; or

R 2 is aryl, heterocyclyl C 3 -C 8 -Cycloalkyl, C 3 -C 8 -Cycloalkenyl; or aryl, heterocyclyl C 3 -C 8 -Cyclo-alkyl or C 3 -C 8 -Cycloalkenyl, which are optionally depending on the substitution possibilities on the ring—substituted with one to five substituents selected from the group consisting of OH, halogen, CN, NO 2 , C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 12 -haloalkyl, C 1 -C 12 -alkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, dimethylamino-C 1 -C 6 -alkoxy, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, methylendioxy, aryl, aryloxy, heterocyclyl and heterocyclyloxy;

R 3 is C 1 -C 8 -alkyl which is substituted with one to five substituents selected from the group consisting of OH, halogen, ON, —N 3 , —NO 2 , C 3 -C 8 -cycloalkyl which is optionally substituted with one to three C 1 -C 6 -alkyl groups, norbornylenyl-, C 3 -C 8 -cycloalkenyl which is optionally substituted with one to three methyl groups; C 3 -C 8 -halocycloalkyl, C 3 -C 8 -cycloalkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, aryl, heterocyclyl, arylthio or heterocyclyloxy; wherein the aryl, heterocyclyl, arylthio and heterocyclyloxy groups are optionally—depending on the substitution possibilities on the ring—substituted with one to five substituents selected form the group consisting of OH, Halogen, CN, NO 2 , C 1 -C 12 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 12 -haloalkyl, C 1 -C 12 -alkoxy, C 1 -C 12 -haloalkoxy, C 1 -C 12 -alkylthio, C 1 -C 12 -haloalkylthio, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, Si(C 1 -C 12 -alkyl) 3 , —X—C(═Y)—R 4 , —X—O(═Y)—Z—R 4 , aryl, aryloxy, heterocyclyl and heterocyclyloxy;

X is O, NR 5 or a bond;

Y is O or S;

Z is O, S or NR 5

R 4 is H, C 1 -C 12 -alkyl which is optionally substituted with one to five substituents selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkoxy and CN; C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 12 -alkyl; or aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are—depending on the substitution possibilities—optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl and C 1 -C 6 -haloalkoxy;

R 5 is H, C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, benzyl or —C(═O)—C 1 -C 12 -alkyl;

R 6 is H, C 1 -C 12 -alkyl which is optionally substituted with halogen, C 1 -C 6 -alkoxy, ON, C 2 -C 8 -alkenyl, C 2 -C 8 -haloalkenyl, C 2 -C 8 -alkinyl, C 1 -C 12 -Haloalkenyl, —X—C(═Y)—R 9 , —X—C(═Y)—Z—R 9 , —SO 2 —R 9 , aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 12 -alkyl; or aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are depending on the substitution possibilities optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl or C 1 -C 6 -haloalkoxy; or

R 4 and R 6 to ether are a three- to five membered alkylene bridge, wherein one of the methylene groups may be replaced by O, S or SO 2 ; and

R 9 is H, C 1 -C 12 -alkyl which is optionally substituted with one to five substituents selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkoxy and CN; C 2 -C 8 -alkenyl, C 2 -C 8 -alkinyl, aryl, heterocyclyl-C 1 -C 12 -alkyl, heterocyclyl-C 1 -C 19 -alkyl; or a aryl, heterocyclyl, aryl-C 1 -C 12 -alkyl or heterocyclyl-C 1 -C 12 -alkyl, which are depending on the substitution possibilities optionally substituted in the ring with one to five substituents selected from the group consisting of halogen, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkyl and C 1 -C 6 -haloalkoxy;

and, where applicable, to E/Z isomers, mixtures of E/Z isomers and/or tautomers, in each case in free form or in salt form.

3. A compound according to claim 1 of the formula (I), wherein R 3 is C 7 -C 8 alkyl.